INTRODUCTION
Obesity is considered as a global epidemic and is associated with hypertension, insulin resistance and metabolic syndromes. [1] [2] Obesity and the related issues contribute significantly to modern healthcare costs, morbidity and mortality. 3 Although several studies have been done to find out the relationship between obesity and Vitamin D deficiency, there is no consensus regarding the opinion that vitamin D deficiency causes obesity. Although researchers have reported that serum vitamin D levels can be a good predictor of obesity the role of vitamin D in lowering body weight is yet to be established. [4] [5] [6] [7] [8] [9] [10] [11] In a study done in the eastern province of Saudi Arabia, the researchers found that the overall prevalence of obesity was 43.8%, and the peak prevalence was in the age group 50-59 years. Obesity was found higher among women than men and significantly higher in housewives, and among the less educated than others.
whether vitamin D deficiency can be the major causative factor for obesity in Saudi women above 40 years of age.
METHODS
After formal approval to conduct the experiments described has been obtained from the human subjects ethical committee of the institution and after taking informed consent, 100 Saudi women above 40 years were selected from the outpatient department of Arar central hospital. The study was done over a period of four months. Women who were on immunosuppressive drugs, who had hormonal disorders and who had renal damage were excluded from the study. A comprehensive questionnaire was given which included the sociodemographic data, height, weight, medical history and drug intake. After completing the questionnaire serum vitamin D level was measured in nmols/l using Elescys 2010 vitamin D Assay (Roche) in the Arar Central Hospital laboratory. Serum vitamin D level below 20 ngms/ml (50 nmols/l) was considered as vitamin D deficiency. 15 The serum vitamin D levels were repeated in another laboratory to validate the results. Vitamin D level ≤12.5 nmols/l was classified as severe vitamin D deficiency, 12.5-25 nmols/l was classified as moderate Vitamin deficiency and >25 nmols/l was classified as mild vitamin D deficiency. 16 After measuring the height in cm and weight in kg, Body Mass Index (BMI) was calculated. The weight was measured with light clothing and no shoes.
The formula used for calculating BMI was Mass (Kilograms)/Height (Meters) 2 . Women having BMI in the range of 18.5-24.9 was considered as normal weight BMI in the range of 25-29.9 was considered as overweight, >30 was considered obese. 17 Women having BMI below 18.5 were considered underweight. Obese women were divided into three groups, Class1 (BMI=30-34.9), Class II (BMI=35-39.9) and class III (BMI≥40.0) according to WHO classification. 18 Logistic regression analysis was used to find out the association between vitamin D deficiency and obesity, hypertension and obesity and diabetes and obesity.
RESULTS
Out of the 100 Saudi women who were selected for the study, 69 Saudi women (69%) had obesity (BMI>30), 23% were overweight (BMI between 25 and 29.9) and 8% had normal body weight (BMI between 18.5 and 24.9). 84% (n=58) of the obese women had vitamin D deficiency (<50 nmols/l), 43.5% (n=30) of obese women had diabetes, 44.9% (n=31) of obese women had hypertension ( Figure 1 Statistical analysis was done using SPSS software. Logistic regression analysis was done to find out the association between vitamin D and obesity, hypertension and obesity and diabetes and obesity. The results showed that there was no significant association between vitamin D deficiency and obesity, hypertension and obesity and diabetes and obesity. The p values were all more than 0.05 indicating that the variables have no significant role in explaining obesity (Table 1) . 
DISCUSSION
The prevalence of common obesity has become a public health concern in many countries as phenomenological approaches to the understanding of obesity have failed to achieve any long term effect on prevention or treatment. 19 Based on, for example, the wide organ distribution of the vitamin D receptor, it is becoming increasingly clear that vitamin D metabolites are not only important in (bone) Ca homeostasis, but also for adequate functioning of many other systems. 20 In addition to its well-known role in osteogenesis, the vitamin D receptor and its ligand impact on lipid accumulation and gene expression in adipose tissue. The vitamin D receptor is expressed in both white and brown adipocytes, and vitamin D and its metabolites are stored in adipose tissue. 21 Other recent studies demonstrated that the 1,25(OH)2D3 regulated, secreted bone protein osteocalcin mediates effects on adipose tissue, β-cells, and energy metabolism. 22 Researchers have reported that vitamin D3 supplementation during weight loss did not increase weight loss or associated factors compared with placebo; however, women who became replete experienced greater improvements. 23 It has been suggested that controlled studies should assess the impact of optimal vitamin D supplementation, with or without added calcium in ethnic groups that are at high risk for insulin resistance and obesity. 24 Vitamin D insufficiency has been shown to be associated with increased risk of developing type 2 diabetes mellitus and cardiovascular disease (CVD), as well as with cardiovascular risk factors such as hypertension and obesity. 25 Contrary to existing evidence, the reports of some researchers did not show significant associations among individual metabolic risk factors such as fasting blood glucose, triglycerides, HDL cholesterol and blood pressure with vitamin D status. 26 There is evidence of aberrations in vitamin D-endocrine system in obese subjects. 27 Recent researches have shown that vitamin D may have a role in obesity. The best form of vitamin D for use in the obese individuals is calcitriol because it is the active form of the vitamin D3 metabolite, its receptors are present in adipocytes, and modulates inflammatory cytokine expression. 28 To date, there is not enough scientific evidence to support the use of vitamin D as a pathway to prevent and/or treat obesity. 29 The results of the present study show that 84% of the obese Saudi women had vitamin D deficiency. These Saudi women were not taking oral vitamin D supplementation due to the lack of awareness. The results have showed the p values more than 0.05 indicating that the variables like vitamin D deficiency, diabetes and hypertension have no significant role in explaining obesity.
There are plausible mechanisms and some in vitro evidence supporting a role for vitamin D in weight reduction, with the proviso that it may be difficult to determine which effects are due to vitamin D itself and which are mediated via calcium. Clinical trials have not been conclusive, at least in part due to variable quality of study design. Some studies showing no effect of vitamin D supplementation on weight included participants who were vitamin D replete, and may thus have shown that giving supplemental vitamin D to those who are replete has no additional effect. There is a clear need for adequately-powered, prospective interventions which include baseline measurement of 25D concentrations and involve adequate doses of supplemental vitamin D. The role of vitamin D supplementation in obesity prevention remains still uncertain.
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CONCLUSION
There was no significant association found between vitamin D deficiency and obesity in Saudi women in our study which suggests that vitamin D deficiency may not be a causative factor for obesity in Saudi women above 40 years of age.
